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Exogenous 5-aminolevulinic acid (ALA) induced protoporphyrin
IX (PPIX) fluorescence endoscopy and photodynamic therapy
(PDT) are new methods for detection and treatment of premalig-
nant and malignant lesions in the gastrointestinal tract (Gossner 
et al, 1998; Endlicher et al, 1999, 2001; Overholt et al, 1999).
ALA is a prodrug in haem biosynthesis, which is converted into
the photosensitizing agent protoporhyrin IX (PPIX). Due to a low
ferrochelatase activity in tumour cells, PPIX accumulates selec-
tively in malignant tissue (Peng et al, 1997; Krieg et al, 2000).
Furthermore PPIX is associated with only limited skin photosensi-
tivity of 1–2 days (Regula et al, 1995). 
In urology fluorescence cystoscopy after local instillation of
ALA into the bladder has significantly enhanced the diagnosis 
of malignant and premalignant bladder lesions (Kriegmair et al,
1996; Filbeck et al, 1999; Koenig et al, 1999). The local applica-
tion of ALA seems to be a promising alternative approach as well
compared to the systemic administration in the detection of malig-
nant and premalignant lesions in the gastrointestinal tract
(Endlicher et al, 1999). 
However, when using ALA topically for the PDT of malignant
and premalignant lesions, this modality appears to be limited by
the amount of uptake and penetration of ALA due to its
hydrophilic nature. Therefore, some lipophilic molecules such as
esterified ALA derivatives have been used both in vitro (Gaullier
et al, 1997; Kloek et al, 1998; Casas et al, 1999; Eleouet et al,
2000), and in vivo (Lange et al, 1999), and better effects were
achieved, compared to the application of unmodified ALA. The
biosynthesis of PPIX induced by ALA esters depends on the
aliphatic length of the alcohol used for esterification. While 
the long-chained ALA-esters (C5–C8) induced a higher PPIX
accumulation in human tumour cell lines, the short-chained ALA-
esters (C1–C3) were less effective (Gaullier et al, 1997;
Washbrook and Riley, 1997), indicating that the mechanism and
rate of uptake of ALA and its esterified derivatives may be
different. Berg et al demonstrated, that the transport of ALA into
human adenocarcinoma cells is mediated by an active transport
mechanism via β -amino acid and gamma aminobutyric acid
carriers, whereas ALA esters are taken up by transporters other
than those used for uptake of ALA or they may penetrate the
plasma membrane by passive diffusion (Rud et al, 2000). 
The aim of the present study was to investigate the comparative
kinetics of PPIX fluorescence in rat colonic tissue for topical
application of ALA and its esterified derivatives. Following our
preclinical studies on different carcinoma cell lines (CaCO2,
SW480 and HT29) with different ALA derivatives we choose h-
ALA and b-ALA because the results indicated that the maximum
benefit for the formation of PPIX is obtained with these esters
(Hausmann et al, 2001). ALA methylester was used for the
comparative study since to our knowledge there are no clinical
data for short-chained ALA esters available. 
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mol ml–1 m-ALA (508 ± 35.50) and 4.8 mol ml–1 h-ALA (532 ± 128.80), and 6 h after sensitization with 4.6 mol ml–1 b-ALA (468 ± 190.27). A
13–18 times lower concentration of ALA esters was required for fluorescence intensities reached with ALA alone. A similar degree of the
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this ratio was consistent with peak fluorescence levels for ALA and each ALA-ester. The clinical feasibility and the advantages of topical ALA
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MATERIAL AND METHODS 
Female CD rats approximately 200 g in weight were used for 
this study. ALA was obtained from medac GmbH, Hamburg,
Germany. ALA methyl-, hexyl- and benzylester were synthesized
at the Institute of Inorganic Chemistry, University of Regensburg.
All experiments were carried out under nitrogen atmosphere. ALA
esters were prepared by reacting ALA with the corresponding
alcohol in the presence of thionyl chloride giving the ALA esters
as the hydrochloride salts (Takeya, 1992). An excess of the freshly
destilled thionyl chloride was added dropwise. Then ALA was
added to the solution and stirred at 60˚C for 5 hours. The excess of
alcohol was evaporated in vacuo. After recrystallization from
methanol/diethylether at –20˚C pure ALA esters were obtained as
white hydrochloride salts. Identification of the synthesized
compounds was based on mass spectroscopy, elemental analysis
and nuclear magnetic resonance (NMR). The protocol for animal
studies was approved by the animal board of Unterfranken,
Germany, adhering to standards required to meet UKCCCR guide-
lines regarding animal ethics. The animals were anaesthetized
with Ketanest©/Rompun© and underwent a small median laparo-
tomy with mobilization of the caecum. After ligation of the
terminal ileum the caecum was incised, a probe placed into the
lumen to wash out faeces by a lavage with about 50 ml of 0.9%
NaCl solution until the fluid became clear. Before sensitization
with 10 ml of a sterile solution of ALA (86.0 mol ml–1: 14.4 mg
ml–1; pH 6.8–7.4), m-ALA (6.6 mol ml–1; 1.2 mg ml–1: pH
8.8–7.4), h-ALA (4.8 mol ml–1: 1.2 mg ml–1; pH 6.8–7.4) or b-
ALA (4.6 mol ml–1: 1.2 mg ml–1; pH 6.8–7.4) the anus was ligated
with a running loop suture. 1, 2, 4 and 6 h after administration of
ALA, m-ALA, h-ALA, b-ALA and additionally 8 h after applica-
tion of b-ALA animals were killed. The entire colon was removed
and 7–9 tissue samples stored immediately in liquid nitrogen. In
addition, tissue from liver and kidney were sampled. The pieces
were prepared in a darkened room in order to avoid photo-
bleaching of the tissue. Frozen sections of 20 µ m thickness were
cut and stored at –80˚C. 
In parallel conventional 5 µ m cryostat sections were cut and
stained with haematoxylin and eosin (H&E) for histological diag-
nosis. For analysis of PPIX fluorescence a fluorescence micro-
scope (Axiovert S 100, Zeiss, Oberkochen, Germany) was used.
Specimen were illuminated by a mercury arc lamp (360 +/–20 nm)
and emitted fluorescence (630 +/–30 nm) was recorded by a high-
sensitive (4096 levels of gray) and high-resolution (1317 × 1035
pixel, with a pixel size of 6.8 × 6.8 µ m) peltier cooled (–15˚C)
CCD-camera (Princeton Instruments NJ, USA), using a 10 × /0.30
PLAN-NEOFLUAR lens. Care was taken to ensure the same
experimental setup for each acquisition (exposure time) to allow
accurate comparability of fluorescence intensities. Specific tissue
layers and whole images (liver, kidney) were analysed using this
technique to determine the relative intensities of porphyrin fluo-
rescence, after correction for autofluorescence levels of each
respective tissue layer as measured on specimens from unsensi-
tized animals (MetaMorph, Universal Imaging Corp, PA, USA).
For confirmation of histology the sections of the microscopic areas
of fluorescence imaging were compared with the stained sections. 
RESULTS 
M-ALA, h-ALA and b-ALA were used in a dose of 6.6 mol ml–1(1.2
mg ml–1), 4.8 mol ml–1 (1.2 mg ml–1) and 4.6 mol ml–1 (1.2 mg ml–1).
4 h after administration of the 3 ALA-esters nearly the same intensity
of porphyrin fluorescence was achieved using a 13- to 18-fold higher
concentration of ALA. Consequently a dose of 86.0 mol ml–1 (14.4
mg ml–1) ALA was used for the fluorescence kinetic study. 
Fluorescence intensity was highest in the mucosa. Figure 1(A–D)
shows the fluorescence levels in the mucosa, muscularis mucosa,
submucosa and muscularis propria. Following administration of
m-ALA and h-ALA fluorescence intensity peaked 4 h after admin-
istration. Fluorescence with b-ALA peaked at 6 h and reached a
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Figure 1A Mean fluorescence intensities (± standard deviation) in the
mucosa, muscularis mucosae, submucosa and muscularis propria at various
times of incubation with ALA (86.0 mol ml–1: 14.4 mg ml–1) 
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Figure 1B Mean fluorescence intensities (± standard deviation) in the
mucosa, muscularis mucosae, submucosa and muscularis propria at various
times of incubation with b-ALA (4.6 mol ml–1: 1.2 mg ml–1) 
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Figure 1C Mean fluorescence intensities (± standard deviation) in the
mucosa, muscularis mucosae, submucosa and muscularis propria at various
times of incubation with h-ALA (4.8 mol ml–1: 1.2 mg ml–1) 1574 E Endlicher et al 
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plateau after 4 h for ALA, respectively, but no further time points
were examined for sensitization with ALA. Peak fluorescence
induced by 4.6 mol ml–1 b-ALA (6 h after application) were higher
than those 4 h after administration of h-ALA (4.8 mol ml–1), m-
ALA (6.6 mol ml–1) and ALA (86.0 mol ml–1). 
Different fluorescence intensities of mucosa and muscularis
propria as represented by fluorescence ratios were achieved
(Figure 2). Following administration of ALA, m-ALA and h-ALA
the highest fluorescence ratios between mucosa and muscularis
propria occured 4 h after sensitization, following application of 
b-ALA the maximum fluorescence ratio was seen at 6 h respec-
tively, in accordance to peak mucosal fluorescence levels. 
In order to evaluate systemic bioavailability after local applica-
tion of ALA, h-ALA, m-ALA and b-ALA PPIX fluorescence
intensity was also measured in liver and kidney at various time
points. 
While the esterified derivatives of ALA (h-ALA 4.8 mol ml–1,
b-ALA 4.6 mol ml–1 and m-ALA 6.6 mol ml–1) induced no
significant increase of PPIX fluorescence intensity in liver and
kidney, application of ALA (86.0 mol ml–1) resulted in higher
values in these organs with a peak or plateau after 4 h (Figures 3
and 4). 
Figure 5 shows a typical microscopic fluorescence image of a
frozen section of the rat colon after sensitization with ALA and 
h-ALA. 
DISCUSSION 
We have investigated the microscopic distribution of ALA-induced
PPIX fluorescence intensity for the esterified derivatives of ALA 
in the rat colon as well as in liver and kidney. We quantified the
PPIX fluorescence at various time intervals after administration of
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Figure 1D Mean fluorescence intensities (± standard deviation) in the
mucosa, muscularis mucosae, submucosa and muscularis propria at various
times of incubation with m-ALA (6.6 mol ml–1: 1.2 mg ml–1) 
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Figure 2 Ratio of mean fluorescence intensities in mucosa and muscularis
propria of rat colon at various times of incubation with ALA and ALA-esters 
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Figure 3 Mean fluorescence intensities (± standard deviation) in the liver at
various times of incubation with different sensitizers 
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Figure 4 Mean fluorescence intensities (± standard deviation) in the kidney
at various times of incubation with different sensitizers 
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Figure 5A Fluorescence image of a frozen section of rat colon 4 h after
local administration of ALA (86.0 mol ml-1: 14.4 mg ml–1): highest
fluorescence intensities are found in the mucosa Fluorescence kinetics of ALA and ALA-esters in rat colon 1575
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ALA, m-ALA, b-ALA and h-ALA. Using quantitative fluores-
cence microscopy the ALA esters induced the same intensity of
PPIX fluorescence using a 13- to 18-fold lower concentration as
compared to ALA. Consequently, at the time of peak mucosal
porphyrin fluorescence intensity we found approximately 3- to 5-
fold higher values in the liver after application of ALA compared to
its derivatives, indicating a lower systemic bioavailability of the
ALA esters. Therefore, with respect to possible side effects the
esterified derivatives may be superior compared to ALA. 
In accordance to data of intravenous or oral administration of
ALA (Loh et al, 1993), following local administration of ALA and
its esterified derivatives as presented here, a rapid build up of PPIX
fluorescence occurred over the first few hours with a plateau after 
4 h. Using a 13- to 18-fold lower concentration of the esterified
derivatives, compared to ALA, the temporal kinetics do not show
any major difference. Thus endogenous esterases do not seem to
have any rate-limiting effect in the tissues investigated. It can be
derived from the results with esterified derivatives of ALA that a
similar incubation time of ALA and ALA esters is advisable for
clinical application in the gastrointestinal tract. This is in contrast to
our in vitro data (Hausmann et al, 2001), indicating a more rapid
increase of ALA ester-induced PPIX fluorescence leading to
shorter incubation times compared to ALA-induced PPIX fluores-
cence. However Lange et al as well demonstrated shorter necessary
incubation times after local ALA ester application for detection of
invisible lesions in the bladder (Lange et al, 1999). 
In contrast to in vitro data indicating short-chained ALA esters
(C1–C3) as less effective in inducing PPIX fluorescence (Gaullier
et al, 1997; Washbrook and Riley, 1997), the administration of 
m-ALA was comparable to h-ALA. The reason for this is
unknown. Since the mechanisms and rate of uptake for 5-ALA and
its esterified derivatives are not completely understood. 
The distribution of ALA- and ALA ester-induced PPIX fluores-
cence intensity was similar showing localization mainly in the
mucosa and approximately 5 times less in the muscularis propria.
Bedwell et al investigated the ALA-induced porphyrin content at
various time intervals, in both normal and tumour tissue in the rat
colon, using fluorescence microscopy and spectroscopy (Bedwell
et al, 1992). In accordance to our data presented for the local applica-
tion mode of ALA, the authors demonstrated that after intravenous
sensitization with ALA the fluorescence was mainly localized in
the normal mucosa, but was 6 times lower in the submucosal tissue
and nearly not detectable in the muscle layer. 
Maximum fluorescence ratios of mucosa and musclularis
propria were accompanied with peak mucosal PPIX fluorescence
with no difference for ALA and its esters. 
Loh et al demonstrated in rat colon, that after intravenous and
oral administration of ALA mucosal PPIX fluorescence intensities
rose to a peak after 4 h, whereas ratios of mean fluorescence levels
in mucosa and muscularis propria peaked 1 h after administration
(Loh et al, 1993). Therefore, our results indicate that the temporal
kinetics of local photosensitization with ALA and its esterified
derivatives are preferable compared to systemic sensitization with
5-ALA. 
Gil et al investigated the possibility of topical 5-ALA adminis-
tration for photodynamic therapy of gut cancer in a mice model
after instillation of a 5-ALA solution at different concentrations
(Gil et al, 1999). The results of fluorescence studies were
compared with those obtained in a control group treated with 5-
ALA given systemically. They found satisfactory epithelial fluo-
rescence levels and good selectivity between gut layers after
intracolonic 5-ALA instillation, however, mean fluorescence
intensity was higher after systemic drug application. 5-ALA esters
as shown here may overcome this limitation of fluorescence inten-
sity compared to 5-ALA. 
In conclusion, the fluorescence kinetic study on the rat colonic
tissue indicates that the local application mode of ALA compared
to systemic administration may be a promising alternative. In view
of clinical data in urology using ALA hexylesters for fluorescence
detection of premalignant and malignant lesions in the bladder
investigations on selectivity of ALA-esters in malignant and
premalignant lesions in the colon are necessary and in progress
(Lange et al, 1999). 
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